Sanjay Kumar Mehta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sanjay Kumar Mehta has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Archita Gupta
Department of Bioengineering and Biotechnology, Birla Institute of Technology, Mesra, Ranchi 835215, Jharkhand, India
1 shared publication - Kanishka Kunal1 shared publication
M. Gautam
West Virginia University, USA
1 shared publication- Rahul Deka
Jyoti and Bhupat Mehta School of Health Science & Technology Indian Institute of Technology Guwahati Guwahati Assam India
1 shared publication - Sneha Singh
Department of Bioengineering and Biotechnology, Birla Institute of Technology, Mesra, Ranchi 835215, Jharkhand, India
1 shared publication
Latest Publications
- 6 June 2024
- Published by Taylor & Francis
- p. 216-243
Modulatory Effects of Phytobioactives in Bone Metabolism and Regeneration
Bone metabolism is a complex process of tissue mineralization and resorption. It is critical to modulate bone metabolism for efficient bone healing and treating bone injuries. Bone has self-regenerating potential, but traumatic events require intervention therapy for healing bones. Plant-derived secondary metabolites or phytobioactives comprise a group of phytoconstituents with promising bone-remodeling properties. Moreover, phytobioactives provide an easily available, cost-effective, and biocompatible alternative therapy for bone healing, overcoming the limitations posed by synthetic osteo-active compounds. Although phytobioactives have been traditionally used for treating bone fractures, recently, different phytobioactives are emerging as new therapeutic agents to modulate different mechanistic pathways involved in bone metabolism. This chapter elaborately discusses different phytobioactives, their structural roles in modulating bone metabolism, and their respective isolation procedures. Furthermore, the effect of the constituents on repairing bone tissues is also explained via different in vitro and in vivo models. The chapter also highlights the promising local delivery strategies that have enhanced the bioavailability of the osteogenic phytobioactives. Phytobioactives-based orthobiologics will assist in designing advanced treatment strategies in bone tissue engineering.
- 6 June 2024
- Published by Taylor & Francis
- p. 216-243
Modulatory Effects of Phytobioactives in Bone Metabolism and Regeneration
Bone metabolism is a complex process of tissue mineralization and resorption. It is critical to modulate bone metabolism for efficient bone healing and treating bone injuries. Bone has self-regenerating potential, but traumatic events require intervention therapy for healing bones. Plant-derived secondary metabolites or phytobioactives comprise a group of phytoconstituents with promising bone-remodeling properties. Moreover, phytobioactives provide an easily available, cost-effective, and biocompatible alternative therapy for bone healing, overcoming the limitations posed by synthetic osteo-active compounds. Although phytobioactives have been traditionally used for treating bone fractures, recently, different phytobioactives are emerging as new therapeutic agents to modulate different mechanistic pathways involved in bone metabolism. This chapter elaborately discusses different phytobioactives, their structural roles in modulating bone metabolism, and their respective isolation procedures. Furthermore, the effect of the constituents on repairing bone tissues is also explained via different in vitro and in vivo models. The chapter also highlights the promising local delivery strategies that have enhanced the bioavailability of the osteogenic phytobioactives. Phytobioactives-based orthobiologics will assist in designing advanced treatment strategies in bone tissue engineering.
- 10 January 2001
- Published by SAE International in SAE International Journal of Advances and Current Practices in Mobility
- Vol. 1
Size Distribution of Particulate Matter from In-Use Heavy Duty Vehicles
The increased use of diesel engines for light-duty and heavy-duty vehicle applications and the associated uncertainties regarding exhaust emissions from these engines on human health has led to focused attention on risk assessments of diesel engine exhaust. Diesel particulate matter, in particular, has been associated with adverse health effects. Some recent epidemiological studies suggest a weak correlation between elevated particulate matter concentration in ambient air and cardiopulmonary health effects. The correlation is even stronger for smaller combustion generated particles (PM2.5). Mortality is mostly due to respiratory and cardiac problems. As associations between particulate matter and respiratory disorders are evidenced more clearly, the need to fully understand and quantify vehicle particle emissions becomes crucial. Compressed and liquefied natural gas fueled engines have significantly reduced total mass emission rates, but at the same time, have contributed a larger portion of this total is ultra-fine particles. In the past two year West Virginia University (WVU) has characterized particle size distribution of particulate matter from over 60 in-use heavy-duty vehicles. Conventional diesel, and several alternative fuels fueled these vehicles, and many of these vehicles were equipped with exhaust after-treatment devices. WVU's Transportable Heavy-Duty Vehicle Emissions Testing Laboratory (THVETL) was used at various sites to test the recruited in-use vehicles. Herein, PM sizing distribution methods and protocols will be discussed and size-distribution data from few of the vehicles test will be presented.
- 10 January 2001
- Published by SAE International in SAE International Journal of Advances and Current Practices in Mobility
- Vol. 1
Size Distribution of Particulate Matter from In-Use Heavy Duty Vehicles
The increased use of diesel engines for light-duty and heavy-duty vehicle applications and the associated uncertainties regarding exhaust emissions from these engines on human health has led to focused attention on risk assessments of diesel engine exhaust. Diesel particulate matter, in particular, has been associated with adverse health effects. Some recent epidemiological studies suggest a weak correlation between elevated particulate matter concentration in ambient air and cardiopulmonary health effects. The correlation is even stronger for smaller combustion generated particles (PM2.5). Mortality is mostly due to respiratory and cardiac problems. As associations between particulate matter and respiratory disorders are evidenced more clearly, the need to fully understand and quantify vehicle particle emissions becomes crucial. Compressed and liquefied natural gas fueled engines have significantly reduced total mass emission rates, but at the same time, have contributed a larger portion of this total is ultra-fine particles. In the past two year West Virginia University (WVU) has characterized particle size distribution of particulate matter from over 60 in-use heavy-duty vehicles. Conventional diesel, and several alternative fuels fueled these vehicles, and many of these vehicles were equipped with exhaust after-treatment devices. WVU's Transportable Heavy-Duty Vehicle Emissions Testing Laboratory (THVETL) was used at various sites to test the recruited in-use vehicles. Herein, PM sizing distribution methods and protocols will be discussed and size-distribution data from few of the vehicles test will be presented.